Top View
- Transcriptional Regulation of CYP2D6 Expression
- Pharmacogenomic Associations Tables
- Differential Expression of Prostaglandin I2 Synthase Associated with Arachidonic Acid Pathway in the Oral Squamous Cell Carcinoma
- University of Groningen Regulation of Metabolizing Enzymes And
- Evolutionary Response to Chemicals in the Environment Introduction To
- Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors As Potential Prostate Cancer Agents
- Free PDF Download
- 46,XX DSD Due to Androgen Excess in Monogenic Disorders of Steroidogenesis: Genetic, Biochemical, and Clinical Features
- Pharmacogenomics of Hypertension Treatment
- 3 INSPRA Eplerenone Tablets DESCRIPTION INSPRA Contains Eplerenone, a Blocker of Aldosterone Binding at the Mineralocorticoi
- Tamoxifen Therapy and CYP2D6 Genotype
- CYP2D6 First It Might Be Helpful to Provide an Overview of the Cytochrome and a Potent Inhibitor of This Enzyme
- CPIC Guidelines for CYP2D6 Genotype and Codeine Therapy – Supplement V.1.0 CPIC Updates
- Analysis of Human Cyp51 Inhibitors”
- Cytochromes P450 (Cyps)
- Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors
- A Functional C–G Polymorphism in the CYP7B1 Promoter Region and Its Different Distribution in Orientals and Caucasians
- Genetic Polymorphism in Dextromethorphan Metabolism by Cyp2d6 and Cyp3a4 Enzyme Isoforms
- Comparison of Lanosterol-14Α-Demethylase
- A Computational Study of the Substrate Conversion and Selective Inhibition of Aldosterone Synthase
- Characterization of the in Vitro Inhibitory Potential of the Oligonucleotide Imetelstat on Human Cytochrome P450 Enzymes with Pr
- The CYP2D6*4 Polymorphism Affects Breast Cancer Survival in Tamoxifen Users Monique J
- Tamoxifen Therapy and CYP2D6 Genotype Laura Dean, MD1 Created: October 7, 2014; Updated: May 3, 2016
- Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors Received: 15 April 2016 Silvia Bonomo1, Cecilie H
- Allelic Distributions of CYP2D6 Gene Copy Number Variation in the East- Ern Han Chinese Population1
- A Review of the Important Role of CYP2D6 in Pharmacogenomics
- Parkinson the Effects of Gender Age Ethnicity and Liver Cirrhosis on P450
- Suicide, Depression, and CYP2D6: How Are They Linked?
- Genetic Evidence That the Human CYP2R1 Enzyme Is a Key Vitamin D 25-Hydroxylase
- Clinical Implications of CYP2D6 Genotyping Intamoxifen Treatment for Breast Cancer Vincent O
- Exploration of Perinatal Pharmacokinetic Issues
- The Metabolization Profile of the CYP2D6 Gene in Amerindian Populations: a Review
- Regulation of the 24-Hydroxylase Gene Promoter by 1,25-Dihydroxyvitamin D3 Adn Chemothereapeutics Drugs
- Regulation of Vitamin D 25-Hydroxylases
- Human Lanosterol 14-Alpha Demethylase (CYP51A1) Is a Putative Target for Natural Flavonoid Luteolin 7,30-Disulfate
- Debrisoquine Hydroxylase (CYP2D6) and Prostate Cancer'
- Alternative Splicing in the Cytochrome P450 Superfamily Expands Protein Diversity to Augment Gene Function and Redirect Human Drug Metabolism S
- Poor Metabolizer #206
- CYP2R1 Is a Major, but Not Exclusive, Contributor to 25-Hydroxyvitamin D Production in Vivo
- Review CYP2D in the Brain
- Cape Baboon Cytochrome P450 11Β-Hydroxylases: The
- The CYP2R1 Enzyme: Structure, Function, Enzymatic Properties and Genetic Polymorphism
- CYP17A1 Inhibitor Abiraterone, an Anti-Prostate Cancer Drug
- Behavioral Health Genotyping Report
- Cytochromes P , Drugs, and Diseases
- UC Davis UC Davis Previously Published Works
- Development of a Fluorescence-Based Trypanosoma Cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
- Hormonal Regulation of the Human CYP27A1 and CYP7B1 Genes
- Lee Washington 0250E 19948.Pdf (10.68Mb)
- Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors
- Intronic Polymorphisms of Cytochromes P450 Magnus Ingelman-Sundberg* and Sarah C